The global pharmaceutical dissolution testing services market is expected to garner a market value of US$ 693.12 Million in 2023 and is expected to accumulate a market value of US$ 1,538.48 Million by registering a CAGR of 8.3% in the forecast period 2023 to 2033. The growth of the pharmaceutical dissolution testing services market can be attributed to a rise in pharmaceutical research efforts. The market for pharmaceutical dissolution testing services registered a CAGR of 5.2% in the historical period 2018 to 2022.
Due to increased Research and Development expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for pharmaceutical dissolution testing services. The dissolution testing services were initially disturbed due to the pandemic.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 693.12 Million |
| Anticipated Forecast Value (2033) | US$ 1,538.48 Million |
| Projected Growth Rate (2023 to 2033) | 8.3% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for pharmaceutical dissolution testing services reflected a value of 5.2% during the historical period, 2018 to 2022.
The COVID-19 pandemic has significantly impacted the global industry. Pharmaceutical firms, biotech firms, and other end-user demands were primarily served during the crisis by developing coronavirus prevention drugs. Since the end of 2019, these organizations have been actively working toward the development of medications that can be used as a treatment for COVID-19 patients who have only minor symptoms. And these drug developments require dissolution testing at each stage to access safety, stability, and efficacy, thus contributing to industry growth. Thus, the market for pharmaceutical dissolution testing services is expected to register a CAGR of 8.3% in the forecast period 2023 to 2033.
Research for Prevention of COVID-19 leading to demand for Pharmaceutical Dissolution Testing Services
The pandemic created an increased workload and a reduction in the internal lab testing capacities of various pharmaceutical companies. However, to mitigate or prevent these challenges, various strategies, like rotational shifts, reducing manpower, and working from home were adopted by companies. By the second half of the pandemic, the research studies for drug development started for the prevention of COVID-19 led to a rise in demand for pharmaceutical dissolution testing services. Dissolution testing is an essential tool for assessing the effectiveness of oral solid dose forms.
Its importance is rising due to the fact that medicine must first be released from the product and dissolved in the gastrointestinal fluids before it can be absorbed into the blood vessels to be effective. In other words, how quickly and how much of a medicine is absorbed depends on how easily it dissolves from the dosage form. According to The Food and Drug Administration Dissolution Database, there are 1444 drug products (July 2022) in the database that are in oral solid dose form. The oral solid dose is relatively simple to administer and it is simple to differentiate one oral solid dose product from another.
Marketing Efforts and Awareness regarding Healthcare Products bolstering demand for Pharmaceutical Dissolution Testing Services
Oral solid dose manufacturing approaches are well-developed. Each has a repeatable distribution of ingredients, as well as uniformity in dissolution and bioavailability, to verify that the drug product is safe and effective. The performance of key companies is highly influenced by the level of demand from end users.
Due to intense market efforts, increasing awareness levels, improving accessibility, and government initiatives; consumers, these days, are more concerned about self-care, resulting in higher consumption of healthcare products. The consumption levels are anticipated to rise exponentially over the forecast period.
Principal Consultant
Unskilled Workforce affecting the growth of the Pharmaceutical Dissolution Testing Services Market
The pharmaceutical dissolution testing services are at a nascent stage. Thus, the trial-and-error format of the industry is hampering the overall growth of the market. Moreover, the absence of unskilled labor to perform various testing services tasks is retaining the growth of the market. Although key players are using technology to increase production and testing services, the unavailability of skilled labor is causing losses to the industry.
Research and Development for Novel Therapeutics accelerating market growth in North America
North America is expected to dominate the global industry in 2023 and account for the maximum share exceeding 50% of the overall revenue. The high share of this segment can be attributed to the presence of major companies providing pharmaceutical dissolution testing services and rising investments in Research and Development by them for the development of novel therapeutics for chronic diseases.
In addition, the development of the healthcare system and a rise in the burden of disease have increased the demand for novel therapeutics and, in turn, the demand for laboratory dissolution testing. All these factors are propelling the growth of the pharmaceutical dissolution testing services market in North America.
Government Initiatives for Research and Development supporting the growth of the market in Asia Pacific
The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period owing to the rising investments by companies from developed economies in enhancing regional healthcare. Furthermore, service providers are establishing new facilities and forming alliances to increase the reach of their offerings to various locations in the region.
In addition, the government of the region is focusing on offering investments for research and development that will accelerate the manufacturing of medicines for different ailments. Thus, Asia Pacific is expected to possess a 33% market share for the pharmaceutical dissolution testing services market in Asia Pacific.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In-vitro dissolution testing is used to evaluate the security of medicines
The in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue. The segment is projected to expand further at the fastest growth rate maintaining its leading industry position throughout the forecast period. Two key factors driving the segment growth include an increase in preclinical pipeline capacity and growing awareness about dissolution testing.
In addition, the market for in-vitro pharmaceutical dissolution testing is anticipated to rise as a result of the traditional rising costs of animal tests as well as their socio-ethical problems. Market expansion is predicted to be supported by significant developments in the in-vitro dissolution testing assays used to evaluate the security of medicines and the potential impacts of those drugs on cells and tissues. To accommodate the rising demand for these assays, businesses are increasing their product lines as the market for in-vitro pharmaceutical dissolution testing expands.
Easy formulation and availability of tablets increasing production of capsules
Based on dosage form, the global industry has been further categorized into capsules, tablets, and others. The other segment includes syrup, ointments, eye/ear/nasal drops, powders, and aerosols.
The tablet dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of 65% of the overall revenue. The segment is also anticipated to register the fastest CAGR maintaining its leading industry position throughout the forecast period.
This rapid growth can be attributed to the fact that tablets are simple to produce in large quantities, have excellent physical and chemical stability, and can be adjusted for the amount of medicine supplied to the body. The capsules segment is anticipated to register the second-fastest CAGR during the forecast period. Capsules are solid dosage forms. Some of the major drivers of this segment are the stability, easy availability of storage conditions, and easy formulation & development of capsules.
Easy Allowance of pH change maximizing use of paddle for manufacturing tablets
Based on dissolution apparatus, the global industry has been further categorized into basket, paddle, and others. The other segment includes a reciprocating cylinder, flow-through cell, paddle-over disc, rotating cylinder, and reciprocating disc. The paddle segment is expected to dominate the industry and account for the largest revenue share of 70% in 2023. The paddle is fixed vertically to a motor with variable speed and controlled speed. The tablet or capsule is put into a flask with a circular bottom for dissolving, and the equipment is kept at a steady temperature. This is widely used for the oral solid dosage form.
It is easy to use, can change pH, and can be easily automated for a routine check-up. The basket dissolution apparatus segment is likely to register the second-fastest CAGR during the forecast period. New equipment is positioned at the revolving shaft's end when using the basket dissolution method. It is made of non-reactive mesh and has a cylindrical form to avoid any unintended chemical interactions that might change the outcome. The main driver for the wide-scale adoption of this method is it can change its pH during the test.
Businesses are undertaking strategies like product launches, M&A agreements, regional expansions, and product launches to gain a competitive edge. Some of the prominent players in the global pharmaceutical dissolution testing services market include Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies, Inc., Catalent, Inc., Thermofisher Scientific Inc, Cambrex, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 693.12 Million |
| Market Value in 2033 | US$ 1,538.48 Million |
| Growth Rate | CAGR of 8.3% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
From 2018 to 2022, the pharmaceutical dissolution testing services market grew at a CAGR of 5.2%
The global pharmaceutical dissolution testing services market is expected to grow with an 8.3% CAGR from 2023 to 2033.
As of 2033, the pharmaceutical dissolution testing services market is expected to reach US$ 1538.48 Million
The tablet dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of more than 65% of the overall revenue.
The paddle segment is expected to dominate the industry and account for the largest revenue share of more than 70% in 2023.
The in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue.
North America is expected to dominate the global industry in 2023 and account for the maximum share of more than 50% of the overall revenue.
Asia Pacific is expected to possess a 33% market share for the pharmaceutical dissolution testing services market in Asia Pacific.
1. Executive Summary | Pharmaceutical Dissolution Testing Services Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Method
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Method, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Method, 2023 to 2033
5.3.1. In Vitro
5.3.2. In Vivo
5.4. Y-o-Y Growth Trend Analysis By Method, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Method, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dosage Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Dosage Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Dosage Form, 2023 to 2033
6.3.1. Capsules
6.3.2. Tablets
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Dosage Form, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dissolution Apparatus
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Dissolution Apparatus, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Dissolution Apparatus, 2023 to 2033
7.3.1. Basket
7.3.2. Paddle
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By Dissolution Apparatus, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Dissolution Apparatus, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa(MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Method
9.2.3. By Dosage Form
9.2.4. By Dissolution Apparatus
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Method
9.3.3. By Dosage Form
9.3.4. By Dissolution Apparatus
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Method
10.2.3. By Dosage Form
10.2.4. By Dissolution Apparatus
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Method
10.3.3. By Dosage Form
10.3.4. By Dissolution Apparatus
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Method
11.2.3. By Dosage Form
11.2.4. By Dissolution Apparatus
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Method
11.3.3. By Dosage Form
11.3.4. By Dissolution Apparatus
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Method
12.2.3. By Dosage Form
12.2.4. By Dissolution Apparatus
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Method
12.3.3. By Dosage Form
12.3.4. By Dissolution Apparatus
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa(MEA)
13.2.2. By Method
13.2.3. By Dosage Form
13.2.4. By Dissolution Apparatus
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Method
13.3.3. By Dosage Form
13.3.4. By Dissolution Apparatus
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Method
14.1.2.2. By Dosage Form
14.1.2.3. By Dissolution Apparatus
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Method
14.2.2.2. By Dosage Form
14.2.2.3. By Dissolution Apparatus
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Method
14.3.2.2. By Dosage Form
14.3.2.3. By Dissolution Apparatus
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Method
14.4.2.2. By Dosage Form
14.4.2.3. By Dissolution Apparatus
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Method
14.5.2.2. By Dosage Form
14.5.2.3. By Dissolution Apparatus
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Method
14.6.2.2. By Dosage Form
14.6.2.3. By Dissolution Apparatus
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Method
14.7.2.2. By Dosage Form
14.7.2.3. By Dissolution Apparatus
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Method
14.8.2.2. By Dosage Form
14.8.2.3. By Dissolution Apparatus
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Method
14.9.2.2. By Dosage Form
14.9.2.3. By Dissolution Apparatus
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Method
14.10.2.2. By Dosage Form
14.10.2.3. By Dissolution Apparatus
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Method
14.11.2.2. By Dosage Form
14.11.2.3. By Dissolution Apparatus
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Method
14.12.2.2. By Dosage Form
14.12.2.3. By Dissolution Apparatus
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Method
14.13.2.2. By Dosage Form
14.13.2.3. By Dissolution Apparatus
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Method
14.14.2.2. By Dosage Form
14.14.2.3. By Dissolution Apparatus
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Method
14.15.2.2. By Dosage Form
14.15.2.3. By Dissolution Apparatus
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Method
14.16.2.2. By Dosage Form
14.16.2.3. By Dissolution Apparatus
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Method
14.17.2.2. By Dosage Form
14.17.2.3. By Dissolution Apparatus
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Method
14.18.2.2. By Dosage Form
14.18.2.3. By Dissolution Apparatus
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Method
14.19.2.2. By Dosage Form
14.19.2.3. By Dissolution Apparatus
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Method
14.20.2.2. By Dosage Form
14.20.2.3. By Dissolution Apparatus
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Method
15.3.3. By Dosage Form
15.3.4. By Dissolution Apparatus
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Intertek Group Plc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Avivia BV
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Almac Group
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Agilent Technologies, Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Catalent, Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Thermo Fisher Scientific Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Cambrex
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Charles River Laboratories
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Boston Analytical
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Pace Analytical Life Sciences
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.11. SOTAX
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.12. AMRI
16.1.12.1. Overview
16.1.12.2. Product Portfolio
16.1.12.3. Profitability by Market Segments
16.1.12.4. Sales Footprint
16.1.12.5. Strategy Overview
16.1.12.5.1. Marketing Strategy
16.1.13. SGS SA
16.1.13.1. Overview
16.1.13.2. Product Portfolio
16.1.13.3. Profitability by Market Segments
16.1.13.4. Sales Footprint
16.1.13.5. Strategy Overview
16.1.13.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Pharmaceutical Dissolution Testing Services Market
